Two whistleblower claims accusing Bayer of promoting its heart surgery drug Trasylol for unapproved purposes will move forward after a New Jersey federal judge on Monday again declined the drug maker’s motion to dismiss the case. In March, U.S. District Judge Jose Linares refused Bayer’s motion to drop the False Claims Act case. Bayer asked Judge Linares to reconsider the March order, arguing that the court missed its arguments that whistleblower Laurie Simpson failed to demonstrate how its alleged wrongful marketing of Trasylol amounted to a submission of false claims to the government. Bayer also argued the court overlooked its ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.